A. Ayyildiz, H. Koc, K. Turkekul, and S. Erdogan, “Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells”, Exp. oncol., vol. 43, no. 2, pp. 125–134, May 2023.